Hepatitis C and steatosis

descriptionPublicationkeyboard_double_arrow_right Article 01 Nov 2004 English Publisher:Elsevier BVJournal:Clinics in Liver Disease, volume 8, pages 881-892 (issn: 1089-3261,

Copyright policy )

Authors: Anouk, Dev; Keyur, Patel; John G, McHutchison;

doi: 10.1016/j.cld.2004.06.007

pmid: 15464660

Hepatitis C and steatosis

- Summary
- Subjects
- Metrics

Abstract

Steatosis is a common finding in patients with chronic hepatitis C (CHC) due to a combination of the direct steatogenic effect of hepatitis C virus (HCV) and the prevalence of metabolic risk factors in the HCV population. Steatosis is now established as a risk factor for disease progression in CHC and significantly impacts therapeutic response. Research efforts should continue to focus on defining the complex viral and host interactions involved in the pathogenesis of HCV-related steatosis so that future therapeutic strategies may be accurately and appropriately targeted.

Related Organizations

Duke Medical Center
United States
Duke University
United States
Duke University Hospital
United States

Keywords

Fatty Liver, Genotype, Risk Factors, Disease Progression, Humans, Hepacivirus, Hepatitis C, Chronic, Antiviral Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	11
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average